Zeerleder SS - Search Results

1

Activated protein C inhibits neutrophil migration in allergic asthma: a randomised trial.

de Boer JD, Berger M, Majoor CJ, Kager LM, Meijers JC, Terpstra S, Nieuwland R, Boing AN, Lutter R, Wouters D, van Mierlo GJ, Zeerleder SS, Bel EH, van't Veer C, de Vos AF, van der Zee JS, van der Poll T. de Boer JD, et al. Among authors: zeerleder ss. Eur Respir J. 2015 Dec;46(6):1636-44. doi: 10.1183/13993003.00459-2015. Epub 2015 Sep 17. Eur Respir J. 2015. PMID: 26381519 Free article. Clinical Trial.

2

Administration of C1 inhibitor reduces neutrophil activation in patients with sepsis.

Zeerleder S, Caliezi C, van Mierlo G, Eerenberg-Belmer A, Sulzer I, Hack CE, Wuillemin WA. Zeerleder S, et al. Clin Diagn Lab Immunol. 2003 Jul;10(4):529-35. doi: 10.1128/cdli.10.4.529-535.2003. Clin Diagn Lab Immunol. 2003. PMID: 12853381 Free PMC article.

3

The effects of continuous venovenous hemofiltration on coagulation activation.

Bouman CS, de Pont AC, Meijers JC, Bakhtiari K, Roem D, Zeerleder S, Wolbink G, Korevaar JC, Levi M, de Jonge E. Bouman CS, et al. Crit Care. 2006;10(5):R150. doi: 10.1186/cc5080. Crit Care. 2006. PMID: 17069648 Free PMC article.

4

C1 inhibitor: just a serine protease inhibitor? New and old considerations on therapeutic applications of C1 inhibitor.

Wouters D, Wagenaar-Bos I, van Ham M, Zeerleder S. Wouters D, et al. Expert Opin Biol Ther. 2008 Aug;8(8):1225-40. doi: 10.1517/14712598.8.8.1225. Expert Opin Biol Ther. 2008. PMID: 18613773 Review.

5

Activated complement is more extensively present in diseased aortic valves than naturally occurring complement inhibitors: a sign of ongoing inflammation.

ter Weeme M, Vonk AB, Kupreishvili K, van Ham M, Zeerleder S, Wouters D, Stooker W, Eijsman L, Van Hinsbergh VW, Krijnen PA, Niessen HW. ter Weeme M, et al. Eur J Clin Invest. 2010 Jan;40(1):4-10. doi: 10.1111/j.1365-2362.2009.02216.x. Epub 2009 Oct 15. Eur J Clin Invest. 2010. PMID: 19843156

6

CD44 is protective during hyperoxia-induced lung injury.

van der Windt GJ, Schouten M, Zeerleder S, Florquin S, van der Poll T. van der Windt GJ, et al. Am J Respir Cell Mol Biol. 2011 Mar;44(3):377-83. doi: 10.1165/rcmb.2010-0158OC. Epub 2010 May 12. Am J Respir Cell Mol Biol. 2011. PMID: 20463290

7

Activation of factor VII-activating protease in human inflammation: a sensor for cell death.

Stephan F, Hazelzet JA, Bulder I, Boermeester MA, van Till JO, van der Poll T, Wuillemin WA, Aarden LA, Zeerleder S. Stephan F, et al. Crit Care. 2011;15(2):R110. doi: 10.1186/cc10131. Epub 2011 Apr 5. Crit Care. 2011. PMID: 21466697 Free PMC article.

8

Prolonged C1 inhibitor administration improves local healing of burn wounds and reduces myocardial inflammation in a rat burn wound model.

Begieneman MP, Kubat B, Ulrich MM, Hahn NE, Stumpf-Stolker Y, Tempelaars M, Middelkoop E, Zeerleder S, Wouters D, van Ham MS, Niessen HW, Krijnen PA. Begieneman MP, et al. J Burn Care Res. 2012 Jul-Aug;33(4):544-51. doi: 10.1097/BCR.0b013e31823bc2fc. J Burn Care Res. 2012. PMID: 22447201

9

Tissue factor pathway inhibitor is an inhibitor of factor VII-activating protease.

Stephan F, Dienava-Verdoold I, Bulder I, Wouters D, Mast AE, Te Velthuis H, Aarden LA, Zeerleder S. Stephan F, et al. J Thromb Haemost. 2012 Jun;10(6):1165-71. doi: 10.1111/j.1538-7836.2012.04712.x. J Thromb Haemost. 2012. PMID: 22449009 Free PMC article.

10

Intrabronchial activated protein C enhances lipopolysaccharide-induced pulmonary responses.

Kager LM, de Boer JD, Bresser P, van der Zee JS, Zeerleder S, Meijers JC, van 't Veer C, van der Poll T. Kager LM, et al. Eur Respir J. 2013 Jul;42(1):188-97. doi: 10.1183/09031936.00057112. Epub 2012 Oct 11. Eur Respir J. 2013. PMID: 23060625 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

170 results

Search Page